Copyright: ©Author(s) 2026.
World J Gastrointest Pharmacol Ther. Jun 5, 2026; 17(2): 118784
Published online Jun 5, 2026. doi: 10.4292/wjgpt.v17.i2.118784
Published online Jun 5, 2026. doi: 10.4292/wjgpt.v17.i2.118784
Figure 1 Study protocol.
SIBO: Small intestinal bacterial overgrowth.
Figure 2 Study flow chart.
GHBT: Glucose hydrogen breath test; TB: Tuberculosis; IBD: Inflammatory bowel disease; CD: Crohn’s disease.
Figure 3 Frequency of small intestinal bacterial overgrowth in patients with acute pancreatitis vs those with healthy controls.
aP < 0.001, categorical variables were compared with Fisher’s exact test (OR = 39.3; 95%CI: 4.8-324.6). SIBO: Small intestinal bacterial overgrowth; OR: Odds ratio; CI: Confidence interval.
Figure 4 Frequency of small intestinal bacterial overgrowth in patients with acute pancreatitis based on the severity of acute pancreatitis.
The prevalence of SIBO increased with disease severity, being 11.1% (95%CI: 1.4%-34.7%) in mild acute pancreatitis, 75.0% (95%CI: 34.9%-96.8%) in moderate disease, and 100% (95%CI: 39.8%-100%) in severe disease (Fisher’s exact test, P < 0.001). SIBO: Small intestinal bacterial overgrowth; CI: Confidence interval.
- Citation: Kumbar C, Vaithiyam V, Reddy RT, Mehta K, Ahuja A, Kumar A, Dalal A, Sachdeva S. Frequency and predictors of small intestinal bacterial overgrowth in acute pancreatitis. World J Gastrointest Pharmacol Ther 2026; 17(2): 118784
- URL: https://www.wjgnet.com/2150-5349/full/v17/i2/118784.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v17.i2.118784